Bluesky Facebook Reddit Email

Long term use of anti-acid drugs may not increase stomach cancer risk

Researchers found no association between long term use of proton pump inhibitors and increased risk of stomach cancer. The study, which analyzed data from five Nordic countries over 26 years, suggests that patients needing long term proton pump inhibitor therapy may not need to worry about a higher risk of stomach cancer.

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Use of acid reflux drugs linked to higher risk of migraine

A study published in Neurology Clinical Practice found an association between the use of acid-reducing drugs and a higher risk of migraine. Researchers analyzed data from 11,818 people and found that those taking proton pump inhibitors were 70% more likely to have migraine.

SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Heart attack risk increases 16-21 percent with use of common antacid

A massive new study by Houston Methodist and Stanford University scientists found that adults using proton pump inhibitors are at a higher risk of experiencing a heart attack. The study examined 16 million clinical documents representing 2.9 million patients and showed no increased heart attack risk for those taking H2 blockers.

Apple iPad Pro 11-inch (M4)

Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.

Spurred by food allergies, 2 esophagus conditions stump doctors

Two esophageal conditions, eosinophilic esophagitis and PPI-responsive esophageal eosinophilia, are so similar that even a biopsy is not enough to distinguish one from the other. Patients may need an 8-week antacid trial and repeat endoscopy for proper diagnosis.